A comment on: "Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial"
- PMID: 36149779
- DOI: 10.1002/ajh.26740
A comment on: "Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial"
Comment in
-
A reply to Moris et al.Am J Hematol. 2022 Dec;97(12):E484. doi: 10.1002/ajh.26738. Epub 2022 Sep 30. Am J Hematol. 2022. PMID: 36134554 No abstract available.
Comment on
-
Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial.Am J Hematol. 2022 Jul;97(7):924-932. doi: 10.1002/ajh.26581. Epub 2022 May 10. Am J Hematol. 2022. PMID: 35472008 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
